Long-Term Survival Outcomes and Treatment Experience of 64 Patients With Esthesioneuroblastoma.

Zeng, Qian; Tian, Yifu; He, Yihong; Xie, Qiongxuan; Ou, Ludi; Wang, Min; Chen, Wen; Wei, Rui

Zeng, Qian; Tian, Yifu; He, Yihong; Xie, Qiongxuan; Ou, Ludi; Wang, Min; Chen, Wen; Wei, Rui.

Afiliación

Zeng Q; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.
Tian Y; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
He Y; Department of Pathology, Xiangya Hospital, Central South University, Changsha, China.
Xie Q; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.
Ou L; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Wang M; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.
Chen W; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Wei R; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.

Front Oncol ; 11: 624960, 2021.

Article en En | MEDLINE | ID: mdl-33747939

Palabras clave

endoscopic surgery; esthesioneuroblastoma; prognostic factors; radiotherapy; survival; treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google